Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
about
Systemic therapy for cervical cancer with potentially regulatable oncolytic adenovirusesThe Promise of Integrins as Effective Targets for Anticancer AgentsThe tumor suppressor gene TP53: implications for cancer management and therapy.Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, Δ24DoubleRGD, in an ovarian cancer modelEpigenetic silencing of the LDOC1 tumor suppressor gene in ovarian cancer cells.Potential of equine herpesvirus 1 as a vector for immunization.Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status.Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition.Role of cell surface molecules and autologous ascitic fluid in determining efficiency of adenoviral transduction of ovarian cancer cells.Reduced expression of the coxsackievirus and adenovirus receptor and of alpha(v) integrins differentiates myelodysplasia-related and primary acute myeloid leukaemia.Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas.
P2860
Q54936836-11E45AB8-4D08-47F9-B2C8-1CFC91289FF5Q54936837-5B1E98EC-0992-4561-85E1-FFF86050348CQ54936838-73A71C16-DF4B-4367-AEA0-C941A3299393Q54936839-59EAD10D-84BC-4B85-8A8A-B30C06ECC3D4Q54936841-79EB1DF3-A3FF-4CB6-8096-E27724278888Q54936845-2F8AB90E-087E-4DC8-A4AE-DB7CBEB5F6B7Q54936846-A47C34A4-E225-487D-9921-79510C9E835AQ54936847-F540EE29-F87B-4FDC-AAF8-1DAC96FC51E5Q54936848-54921A4F-B545-4978-B38E-A6E23AA2C03AQ54936849-5ECF3441-AA03-49DD-BDC7-3E51A39DFB12Q54936850-2B328233-D319-4E1B-877E-577840719634Q54936852-9AD73548-E5F9-450E-8748-9AD4BDF48B53Q54936858-202C83CC-484F-43D6-B3BD-D2D834B4E4AFQ54936859-DA2E5CDE-D778-4406-8BE4-89DA44198C36Q54936860-B2BC8B7C-9781-4186-A8AA-DFEA971AD3C9Q54936861-EFAB65B5-6A17-4435-B8D8-81569D1197BEQ54936862-493A2BC8-7422-48F0-BCBA-32EA2EDC39DEQ54936863-E607F1D4-A314-4176-9B9B-CA36376B5461Q54936864-01A73474-05DB-4ADA-B41E-1165035E702EQ54936866-AFF5A762-D60C-4849-BC60-AB3FD4442BC4Q54936868-FEF5A373-0E37-4B59-AF2C-44C3DFFB9F0AQ54936870-043B9DE9-2FE9-44F5-A423-359EFBC78F59Q54936871-5B1D1397-62BB-43DB-AD74-B94D323E3A1AQ54936872-9C196F91-C1C5-483D-855D-EFD39F10146AQ54936875-628CE54A-E8BD-4194-AA7C-DFFB594490FA
P1343
Q21144267-CAB16719-A314-4A12-9A3C-5749B371F41FQ24801503-82169219-E002-43CB-9941-CC4CEB12AD76Q35986418-7DB1C2EB-C9F6-457F-8A27-764EA0EB05BDQ37127836-98EFF789-DAF3-4739-8C76-DBADF7575589Q39022355-B4D2EC63-C504-4960-9EBB-83B2B2AB6D4EQ40436034-3BEA6C84-5D90-4021-9A3F-0893F16E7F6DQ40553784-1DD5E43C-A717-4A3B-9189-C6879F75181BQ41575123-EFC58925-591F-4547-8256-9844893310C4Q43030471-17EF8C0E-8C04-4A62-AA17-3790B09E2722Q43748735-ADC7884D-D460-491D-B50C-169D088890BEQ44270897-D6816FBF-E351-4316-AB38-5F5678D87A1F
P2860
Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Adenoviral transduction effici ...... ution of integrin alphavbeta3.
@en
type
label
Adenoviral transduction effici ...... ution of integrin alphavbeta3.
@en
prefLabel
Adenoviral transduction effici ...... ution of integrin alphavbeta3.
@en
P2093
P4510
P921
P1433
P1476
Adenoviral transduction effici ...... ution of integrin alphavbeta3.
@en
P2093
P304
P356
10.1089/10430340150504019
P577
2001-03-01T00:00:00Z